These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 33976733)
1. Increased Expression of Deng P; Zhou R; Zhang J; Cao L J Cancer; 2021; 12(11):3239-3248. PubMed ID: 33976733 [No Abstract] [Full Text] [Related]
2. KNSTRN Is a Prognostic Biomarker That Is Correlated with Immune Infiltration in Breast Cancer and Promotes Cell Cycle and Proliferation. Zhang W; Xiao Y; Zhou Q; Zhu X; Zhang Y; Xiang Q; Wu S; Song X; Zhao J; Yuan R; Xiao B; Li L Biochem Genet; 2024 Oct; 62(5):3709-3739. PubMed ID: 38198023 [TBL] [Abstract][Full Text] [Related]
3. Validating Li X; Zuo H; Zhang L; Sun Q; Xin Y; Zhang L Front Oncol; 2021; 11():720302. PubMed ID: 34527588 [TBL] [Abstract][Full Text] [Related]
4. High expression of RRM2 as an independent predictive factor of poor prognosis in patients with lung adenocarcinoma. Jin CY; Du L; Nuerlan AH; Wang XL; Yang YW; Guo R Aging (Albany NY); 2020 Dec; 13(3):3518-3535. PubMed ID: 33411689 [TBL] [Abstract][Full Text] [Related]
5. TICRR as a potential prognostic biomarker for lung adenocarcinoma: A comprehensive analysis using TCGA database. Zhang Z; Huang C; Wu J; Cheng Q; Wang S Medicine (Baltimore); 2024 Jul; 103(27):e38660. PubMed ID: 38968480 [TBL] [Abstract][Full Text] [Related]
6. Long Non-Coding RNA-TMPO-AS1 as ceRNA Binding to let-7c-5p Upregulates STRIP2 Expression and Predicts Poor Prognosis in Lung Adenocarcinoma. Wang J; Yuan Y; Tang L; Zhai H; Zhang D; Duan L; Jiang X; Li C Front Oncol; 2022; 12():921200. PubMed ID: 35774125 [TBL] [Abstract][Full Text] [Related]
7. Expression and prognostic analysis of Rho GTPase-activating protein 11A in lung adenocarcinoma. Chen S; Duan H; Xie Y; Li X; Zhao Y Ann Transl Med; 2021 May; 9(10):872. PubMed ID: 34164506 [TBL] [Abstract][Full Text] [Related]
8. NamiRNA-mediated high expression of KNSTRN correlates with poor prognosis and immune infiltration in hepatocellular carcinoma. Jin L; Zhang X; Fan M; Li W; Zhang X Contemp Oncol (Pozn); 2023; 27(3):163-175. PubMed ID: 38239867 [TBL] [Abstract][Full Text] [Related]
9. Elevated Heterogeneous Nuclear Ribonucleoprotein C Expression Correlates With Poor Prognosis in Patients With Surgically Resected Lung Adenocarcinoma. Guo W; Huai Q; Zhang G; Guo L; Song P; Xue X; Tan F; Xue Q; Gao S; He J Front Oncol; 2020; 10():598437. PubMed ID: 33569346 [TBL] [Abstract][Full Text] [Related]
10. Zhang W; Liao Y; Liu C; Liu L; Zhou X Dis Markers; 2023; 2023():6729717. PubMed ID: 36845017 [TBL] [Abstract][Full Text] [Related]
11. High expression of PIMREG predicts poor survival outcomes and is correlated with immune infiltrates in lung adenocarcinoma. Jiang F; Liang M; Huang X; Shi W; Wang Y PeerJ; 2021; 9():e11697. PubMed ID: 34268011 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of CDC25C in lung adenocarcinoma: An analysis of TCGA data. Xia Z; Ou-Yang W; Hu T; Du K Cancer Genet; 2019 Apr; 233-234():67-74. PubMed ID: 31109596 [TBL] [Abstract][Full Text] [Related]
13. Jiang F; Huang X; Yang X; Zhou H; Wang Y Front Oncol; 2022; 12():795971. PubMed ID: 35814368 [TBL] [Abstract][Full Text] [Related]
14. CDCA4 as a novel molecular biomarker of poor prognosis in patients with lung adenocarcinoma. Tan J; Chen F; Ouyang B; Li X; Zhang W; Gao X Front Oncol; 2022; 12():865756. PubMed ID: 36185189 [TBL] [Abstract][Full Text] [Related]
15. High DSCC1 Level Predicts Poor Prognosis of Lung Adenocarcinoma. Chang S; Zhu Y; Xi Y; Gao F; Lu J; Dong L; Ma C; Li H Int J Gen Med; 2021; 14():6961-6974. PubMed ID: 34707388 [TBL] [Abstract][Full Text] [Related]
16. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma. Zuo S; Wei M; Wang S; Dong J; Wei J Front Immunol; 2020; 11():1218. PubMed ID: 32714316 [No Abstract] [Full Text] [Related]
17. A Seven-Gene Signature with Close Immune Correlation Was Identified for Survival Prediction of Lung Adenocarcinoma. Zou X; Hu Z; Huang C; Chang J Med Sci Monit; 2020 Jul; 26():e924269. PubMed ID: 32613949 [TBL] [Abstract][Full Text] [Related]
18. SPAG5 Expression Predicts Poor Prognosis and is Associated With Adverse Immune Infiltration in Lung Adenocarcinomas. Xiao G; Xu X; Chen Z; Zeng J; Xie J Clin Med Insights Oncol; 2023; 17():11795549231199915. PubMed ID: 37744424 [TBL] [Abstract][Full Text] [Related]
19. FUT4 is involved in PD-1-related immunosuppression and leads to worse survival in patients with operable lung adenocarcinoma. Liu C; Li Z; Wang S; Fan Y; Zhang S; Yang X; Hou K; Tong J; Hu X; Shi X; Wang X; Liu Y; Che X; Qu X J Cancer Res Clin Oncol; 2019 Jan; 145(1):65-76. PubMed ID: 30357521 [TBL] [Abstract][Full Text] [Related]
20. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma. Ma C; Kang W; Yu L; Yang Z; Ding T Front Oncol; 2020; 10():590006. PubMed ID: 33363020 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]